Atherectomy Devices Market Size & Forecast

Download Free Sample View Report Summary

Historic: 2022-2024 Base Year: 2025 Forecast: 2026–2033

US$ 890.0 Million

Market Size 2025 · Base Year

US$ 1,623.0 Million

Projected Market Size by 2033

7.8%

CAGR · 2026–2033

At a Glance

Report Coverage

56 +

Countries

56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa

Year Assessment

Comprehensive Market Analysis Covering 3 Years of Historical Data (2022–2024), Base Year (2025), and 8-Year Forecast (2026–2033)

10 +

Major Players

Major companies profiled including Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Koninklijke Philips N.V., Terumo Corporation

400

Report Pages

Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets

What's Fueling Growth

Market Drivers

Rising prevalence of peripheral artery disease (PAD) and cardiovascular diseases increasing demand for plaque removal procedures
Growing preference for minimally invasive procedures due to faster recovery and reduced complications
Continuous technological advancements improving device precision, safety, and clinical outcomess

Where Growth Opportunities Exist

Key Opportunities

Expansion in emerging markets driven by improving healthcare infrastructure and rising patient awareness
Development of next-generation devices targeting complex and calcified lesions
Growing adoption of combination therapies (atherectomy with drug-coated balloons or stents) enhancing treatment outcomes

What Could Slow It Down

Market Restraints

High cost of devices and procedures limiting adoption, especially in low- and middle-income regions
Risk of procedural complications such as embolization and arterial damage affecting clinical preference
Regulatory challenges and inconsistent reimbursement policies slowing market penetration

Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

Abbott Laboratories

Boston Scientific Corporation

Medtronic plc

Koninklijke Philips N.V.

Terumo Corporation

Becton, Dickinson and Company (BD)

AngioDynamics, Inc.

Avinger, Inc.

Cardiovascular Systems, Inc. (CSI)

Straub Medical AG

What's Inside

Report Scope & Deliverables

Market Size 2025	US$ 890.0 Million
Market Size 2033	US$ 1,623.0 Million
CAGR 2026–2033	7.8%
Segments	By Product (Rotational Atherectomy Systems, Directional Atherectomy Systems, Orbital Atherectomy Systems) \| By Application (Cardiovascular, Peripheral Vascular, and Neurovascular) \| By End User (Hospitals and Ambulatory Surgical Centers)
Geographies	North America (US, Canada, Mexico) · Europe (Belgium, Austria, Finland, Denmark, Greece, Poland, Romania, Russia, Ukraine, Czech Republic, Slovakia, Bulgaria, Italy, Luxembourg, Germany, Switzerland, France, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom) · Asia-Pacific (Australia, China, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Bangladesh, New Zealand, Taiwan) · South and Central America (Brazil, Argentina, Peru, Chile, Colombia) · Middle East and Africa (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Turkiye, South Africa, Egypt, Algeria, Nigeria)
Deliverables	Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code	BMIPUB00035110
Lead Analyst	Siddhika Potpelwar — Consultant, Research & Consulting · View Profile

With Full Report Access

Gain actionable insights with 400 pages of in-depth Atherectomy Devices Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.

View Report Summary Download Free Sample

Atherectomy Devices Market Size & Forecast

Report Coverage

Market Drivers

Rising prevalence of peripheral artery disease (PAD) and cardiovascular diseases increasing demand for plaque removal procedures

Growing preference for minimally invasive procedures due to faster recovery and reduced complications

Continuous technological advancements improving device precision, safety, and clinical outcomess

Key Opportunities

Expansion in emerging markets driven by improving healthcare infrastructure and rising patient awareness

Development of next-generation devices targeting complex and calcified lesions

Growing adoption of combination therapies (atherectomy with drug-coated balloons or stents) enhancing treatment outcomes

Market Restraints

High cost of devices and procedures limiting adoption, especially in low- and middle-income regions

Risk of procedural complications such as embolization and arterial damage affecting clinical preference

Regulatory challenges and inconsistent reimbursement policies slowing market penetration

Coverage by Segment

Product

Application

End User

Regional Intelligence

Major Market Players

Report Scope & Deliverables